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Since 2007, there has been a re-emergence of cholera outbreaks in northern Vietnam. To
understand the molecular epidemiological relatedness and determine the antibiotic susceptibility
profiles of responsible V. cholerae O1 outbreak strains, a representative collection of 100
V. cholerae O1 strains was characterized. V. cholerae O1 strains isolated from diarrhoeal patients
in northern Vietnam between 2007 and 2010 were investigated for antibiotic susceptibility and
characterized by using phenotypic and genotypic tests, including PFGE analysis. Ten clinical
V. cholerae O1 isolates from Bangladesh and Zimbabwe were included for comparison. The
results revealed that all isolates were resistant to co-trimoxazole and nalidixic acid, 29% were
resistant to tetracycline and 1% were resistant to azithromycin. All strains were susceptible to
ampicillin–sulbactam, doxycycline, chloramphenicol and ciprofloxacin and 95% were susceptible
to azithromycin. MIC values did show reduced susceptibility to fluoroquinolones and 63% of the
strains were intermediately resistant to tetracycline. The isolates expressed phenotypic traits of
both serogroup O1 Ogawa and El Tor and harboured an rstR El Tor and ctxB classical biotype.
Among the outbreak isolates, only a single PFGE pattern was observed throughout the study
period. This study shows that multi-drug resistant V. cholerae altered El Tor producing classical
CT strains are now predominant in northern Vietnam.
INTRODUCTION
Cholera is an acute diarrhoeal disease, causing profuse
watery stools, which, if untreated, leads to rapid dehydra-
tion and death (Kaper et al., 1995). Cholera is prevalent in
developing countries with inadequate sanitation and
poor access to safe drinking water (Zuckerman et al.,
2007). From 1995 to 2005, approximately 100000–300000
cases of cholera causing 1500 deaths were reported annually
to the WHO (Griffith et al., 2006). Cholera is caused by the
Gram-negativebacteriumVibriocholerae serogroupsO1and
O139 (Kaper et al., 1995). Serogroup O1 can be categorized
into two biotypes (classical or El Tor), and three serotypes
Abbreviations: CTX, cholera toxin; MAMA, mismatch amplification
mutation assay; UPGMA, unweighted pair group method with arithmetic
mean.
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034744 G 2012 SGM Printed in Great Britain 431(Ogawa, Inaba or Hikojima) (Sack et al., 2004). The seventh,
and current, pandemic of cholera is being caused by the El
Tor biotype while the fifth and sixth pandemics of cholera
were caused by the classical biotype (Alam et al., 2010).
Recently, new variants of V. cholerae O1 have emerged and
spread throughout many countries of Asia, Africa and
America that display a mixture of phenotypic and genotypic
traits of both classical and El Tor biotypes (Alam et al., 2010;
Ansaruzzaman et al., 2007).
Since the first variants of V. cholerae O1 El Tor were
identified in Bangladesh, several other atypical El Tor
strains have been identified and reported (Ansaruzzaman
et al., 2007; Choi et al., 2010). Genotypic tests to
differentiate V. cholerae O1 biotypes include ctxB (cholera
toxin B), rstR (repeat sequence transcriptional) and tcpA
(toxin-coregulated pili) gene typing (Safa et al., 2010). The
El Tor strains that cause cholera in many countries have
shifted from genotype 3 (found in El Tor strains from the
seventh pandemic and the Latin American epidemic) to
genotype 1 (found in strains of classical biotype worldwide
and US Gulf Coast El Tor strains). In addition, atypical El
Tor strains of V. cholerae O1 from Asia and Africa
harboured an rstR allele known as rstR
Classical, which
corresponds with CTXW
Classical and are reported as hybrid
strains of the El Tor biotype (Ansaruzzaman et al., 2004).
Moreover, the multi-drug resistant V. cholerae O1 altered
El Tor has emerged as major problem in many countries in
Asia and Africa (Ang et al., 2010; Jain et al., 2011; Kumar
et al., 2010; Quilici et al., 2010).
In 2007, a cholera outbreak emerged in northern Vietnam,
where only a few cases of cholera had previously been
reported (Dalsgaard et al., 1999). The strains of V. cholerae
O1 responsible for this outbreak were variants of the El
Tor biotype displaying combinations of classical and El
Tor features (Nguyen et al., 2009). New cholera cases
continued to be detected in northern Vietnam until 2010,
especially in Hanoi. The V. cholerae O1 strains associated
with cholera outbreaks between 2007 and 2010 in
northern Vietnam have not yet been characterized and
their susceptibility to antimicrobials has not been
reported. Moreover, there is lack of information about
the genetic diversity among V. cholerae O1 strains isolated
from patients in northern Vietnam between 2007 and
2010.
In the present study, we investigated the antimicrobial
susceptibilities and the molecular epidemiological traits of
V. cholerae O1 strains isolated in northern Vietnam from
2007 to 2010. V. cholerae O1 strains from Bangladesh and
Zimbabwe were also included for comparison.
METHODS
Bacterial strains. In this study, we combined two collections of V.
cholerae O1 strains that were selected randomly from diarrhoeal
patients admitted to the National Hospital for Tropical Diseases
(NHTD), a tertiary-care hospital in Hanoi, Vietnam. The NHTD
served as a referral centre during the cholera outbreaks in Hanoi
and the surrounding areas between 2007 and 2010. Antimicrobial
susceptibility testing was performed on 100 isolates from patients
admitted in 2008. A second collection contained 100 randomly
selected strains isolated from patients with acute diarrhoea who
were admitted to the NHTD between 2007 and 2010 (25 isolates for
each year). V. cholerae was identified and confirmed by using
standard biochemical methods (Islam et al., 2009). Serological
identification of isolates was done by performing slide agglutination
tests with commercially available polyvalent antiserum against V.
cholerae O1 and monovalent antiserum against V. cholerae O1
serogroups Ogawa and Inaba (Bio-Rad) (Dalsgaard et al., 1999). The
second collection was shipped in soft agar at ambient temperature
to the ICDDR,B for phenotypic and genotypic testing and PFGE
analysis. Reference strains for each of the V. cholerae O1 biotypes
were used: classical (O395) and El Tor (N16961). Ten clinical
isolates each of V. cholera O1 from Bangladesh and Zimbabwe were
included for comparison.
Serotyping and biotyping. Vietnamese V. cholerae strains were
serotyped by using the slide agglutination test with specific polyvalent
antiserum to V. cholerae O1 and serotype specific antisera to Inaba
and Ogawa from the ICDDR,B (Ansaruzzaman et al., 2004). For
biotype analysis, we used chicken erythrocyte agglutination, sensitiv-
ity to polymycin B and Mukerjee classical phage IV and Mukerjee El
Tor phage 5 tests (Kaper et al., 1995; Sack et al., 2004).
PCR assays. The characterization of biotype and genotype were
performed with molecular methods. Species-specific identification of
V. cholerae was carried out by using V. cholerae species-specific ompW
PCR (Nandi et al., 2000). The serogroups of these strains were
reconfirmed by multiplex PCR targeted to identify genes encoding O1
(rfb) and O139 (rfb), specific O biosynthetic genes and the cholera
toxin (CTX) gene (ctxA) (Hoshino et al., 1998). Biotype specific
characterizations were performed by using PCR assays targeted to
detect tcpA (Classical and El Tor) (Keasler & Hall, 1993) and the type
of the rstR (El Tor and Classical alleles) gene encoding the phage
transcriptional regulator (Bhattacharya et al., 2006). Mismatch
amplification mutation assay (MAMA)-PCR to detect sequence
polymorphism between the classical and El Tor ctxB gene was
performed to distinguish the type of CTXB of the V. cholerae O1
strains included in this study (Morita et al., 2008); primers and
procedures were used as described previously (Alam et al., 2010).
Antimicrobial susceptibility. Antimicrobial susceptibility to ampi-
cillin (AMP), ampicillin/sulbactam (AXS), nalidixic acid (NAL),
ciprofloxacin (CIP), trimethoprim/sulfamethoxazole (SXT), chlor-
amphenicol (CHL), tetracycline (TCY), levofloxacin (LVX), azithro-
mycin (AZM), doxycycline (DOX) was determined using E-test strips
(bioMe ´rieux), according to the manufacturer’s instructions. Cut-off
levels for assessing resistance were used according to CLSI document
M45 guidelines (CLSI, 2010a). For nalidixic acid, the MIC break
point for Enterobacteriaceae was used, as published in CLSI document
M100 (CLSI, 2010b).
PFGE. Intact agarose-embedded chromosomal DNA from 16
representative strains of V. cholerae O1 from Vietnam and four
strains from Bangladesh and Zimbabwe was prepared and PFGE
was performed using contour-clamped homogeneous electric field
apparatus (Bio-Rad) according to the PulseNet procedure (Cooper
et al., 2006). Genomic DNA was digested with the NotI restriction
enzyme (Gibco-BRL). The electrophoresis was performed by using
CHEF-DRII system apparatus and conditions. Images were captured
and converted to TIF files for computer analysis (Nusrin et al., 2009).
Salmonella enterica serotype Braenderup strain H9812 was used as a
molecular size marker.
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Serotyping and biotyping
Serogrouping and bio-typing of Vietnamese V. cholerae
strains revealed that all the strains belonged to the sero-
group O1 Ogawa and the biotype El Tor (Table 1). Slide
agglutination tests with antisera showed that all strains were
positive to polyvalentO1 andmonovalentOgawa. Biotyping
showed that all strains were resistant to polymycin B 50 IU,
agglutinated to chicken erythrocytes and were resistant to
classical phage IV and sensitive to El Tor phage 5, which are
typical traits of the El Tor biotype.
PCR assays
Examination of genotypic traits also confirmed that the
Vietnamese V. cholerae were of the O1 serogroup and
altered El Tor variant (Table 1). PCRs for the V. cholerae
species-specific gene ompW and serogroup-specific gene
rfbO1 were positive for all strains. All strains harboured
rstR
El and tcpA genes which are specific to strains of the El
Tor biotype. Results of MAMA-PCR showed that all the V.
cholerae isolates from Vietnam in this study harboured the
ctxB1 allele which had been identified in strains of the
classical biotype worldwide and in US Gulf Coast El Tor
strains. All strains were positive for the ctxA gene.
Antimicrobial susceptibility
The percentages of the isolates that were susceptible,
intermediately resistant or resistant to each microbial agent
as well as the mean and range of MIC values are presented in
Table 2. The data revealed that the isolates were suscep-
tible to amipicillin (98%), ampicillin/sulbactam (100%),
doxycycline (100%), chloramphenicol (100%), ciprofloxacin
(100%), levofloxacin (100%), and azithromycin (95%).
However, the isolates exhibited high rate of resistance to
trimethoprim/sulfamethoxazole (100%), nalidixic acid (100%)
and tetracycline (29%). In addition, most isolates were inter-
mediately resistant to tetracycline (63%).
There were four resistance patterns (Table 3) among the 100
strains tested. The most prevalent pattern was a resistance to
nalidixic acid, co-trimoxazole and tetracycline (including
cases of intermediate resistance).
PFGE
In the present study, PFGE analysis of the representative
Vietnamese strains isolated between 2007 and 2010 showed
an indistinguishable PFGE banding pattern that was typical
ofV.cholerae O1ElTor(Fig.1).TheNotIrestrictionenzyme
cleaved the chromosomal genome into 18 fragments with
fragment sizes ranging from 20 to 398 kb. The PFGE
patterns of isolates from Bangladesh and Zimbabwe differed
slightly from the Vietnamese strains by a single band posi-
tion, suggesting genetic divergence (Fig. 1).
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http://jmm.sgmjournals.org 433When cluster analysis was performed to produce dendro-
grams, prepared using the Dice similarity coefficient and
unweighted pair group method with arithmetic mean
(UPGMA) clustering, using the PFGE patterns, all the El
Tor strains shared a major cluster (Fig. 2) in which all the
Vietnamese strains shared 100% similarity, whereas the
Bangladesh and Zimbabwe strains formed another closely
related cluster showing 98% similarity to the Vietnamese
strains.
The PFGE (Fig. 1) results also indicate that the altered
strains from Vietnam are more closely related to the El Tor
reference strain (N16961) than to the classical reference
strain (O395).
DISCUSSION
According to the new biotyping scheme proposed for V.
cholerae O1 (Raychoudhuri et al.,2 0 0 8 ) ,t h er e s u l t ss h o w
that the Vietnamese V. cholerae O1 strains are variant El Tor
strains. The strains have phenotypic traits of the El Tor biotype
and genotypic traits of both El Tor and classical biotypes
(rstR
El/ctxB1). These variant strains were first reported in
Bangladesh (Nair et al., 2002, 2006). The emergence and
spread of a new variant of V. cholerae O1 urges the redefinition
of V. cholerae classification (Raychoudhuri et al., 2008; Safa
et al., 2010). Recently, a new biotyping scheme was proposed,
using the molecular marker genes ctxB, rtxC, tlc, tcpA and RS
element, which added a further two biotypes, designated
‘hybrid’ and ‘El Tor variant’, to the classification of newly
emerging V. cholerae O1 strains (Raychoudhuri et al., 2008).
Earlier work already showed that cholera outbreaks in
northern Vietnam in 2007 and early 2008 were caused by a
V. cholerae O1 El Tor variant biotype strain producing
‘classical’ CTXB. This El Tor variant strain was probably
imported into northern Vietnam around 2007 and subse-
quently replaced the endemic strains which contained a
tandem repeat of the classical CTX prophage on the small
chromosome, similar to the Mozambican variant, and were
responsible for small cholera outbreaks before 2007 in
Vietnam (Nguyen et al., 2009). Our genotyping data reveal
that cholera outbreaks in northern Vietnam between 2007
and 2010 were caused by a single clone, confirming that the
new V. cholerae O1 El Tor variant strain is predominant and
has replaced the traditional El Tor biotype.
Table 2. Antimicrobial susceptibility profile of V. cholerae O1 strains using the E-test method
All MIC values are given in mgm l
21. ND, Not determined.
Antimicrobial(s) No.
strains
Resistance pattern Mean
MICvalues
Range of
MIC values
Sensitive Intermediately
resistant
Resistant MIC50 MIC90
Percentage of
strains tested
MIC Percentage of
strains tested
MIC Percentage of
strains tested
MIC
Ampicillin 100 98 ¡8 2 16 0 ¢32 3 6 1–12
Ampicillin/
sulbactam (2/1)
92 100 ¡8/4 0 16/8 0 ¢32/16 3 3 ,8/4
Tetracycline 100 8 ¡46 3 82 9 ¢16 8 12 1–24
Doxycycline 97 100 ¡40 80 ¢16 2 2 0.25–3
Trimethoprim/
sulfamethoxazole
(1/19)
100 0 ¡2/38 0 ND 100 ¢4/76 32 32 .4/76
Chloramphenicol 100 100 ¡8 0 16 0 ¢32 0.5 0.75 0.38–1
Ciprofloxacin 100 100 ¡10 20 ¢4 0.38 0.5 0.125–0.75
Levofloxacin 100 100 ¡20 40 ¢8 0.38 0.5 0.125–0.75
Nalidixic acid* 100 0 ¡16 0 ND 100 ¢32 256 256 256–256
Azithromycin 100 95 ¡24 41 ¢8 1.5 2 0.25–32
*MIC interpretive standard for Enterobacteriaceae.
Table 3. Antibiotic resistance profiles of both intermediately
resistant and resistant V. cholerae O1 isolates
AMP, ampicillin; AXS, ampicillin/sulbactam; NAL, nalidixic acid;
CIP, ciprofloxacin; SXT, trimethoprim/sulfamethoxazole; CHL,
chloramphenicol; TCY, tetracycline; LVX, levofloxacin; AZM, azi-
thromycin, DOX, doxycycline.
Type Antibiotic resistance profile No. strains
I NAL, SXT 8
II NAL, SXT, TCY 85
III AZM, NAL, SXT, TCY 5
IV AMP, NAL, SXT, TCY 2
Total 100
H. D. Tran and others
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isolated in Bangladesh after 2001 were atypical or El Tor
variant strains as they were phenotypically and genetically
similar to El Tor but had the ctxB1 gene of the classical
biotype (Nair et al., 2002, 2006). Subsequent studies
reported such variant strains in Mozambique (Ansaruzza-
man et al.,2 0 0 4 ) ,V i e t n a m( N g u y e net al.,2 0 0 9 ) ,
Zimbabwe (this study) and Mexico (Alam et al.,2 0 1 0 ) .
Although the Vietnamese V. cholerae strains isolated
between 2007 and 2010 were of the El Tor variant bio-
type and had PFGE patterns closely related to those of V.
cholerae strains isolated from contemporary cholera out-
breaks in Zimbabwe and Bangladesh, they had minor but
consistent divergences, suggesting that the Vietnamese
strains had an independent lineage and occupied a local
niche.
Using multi-locus variable number tandem repeat analysis,
a recent study demonstrated that altered strains from
Vietnam are distant from the El Tor prototype strain
responsible for the seventh cholera pandemic (Choi et al.,
2010). In spite of the minor divergences observed in the
present study, the Vietnamese V. cholerae O1 strains with
the RS1–CTX prophage (El Tor type rstR and classical
ctxB) array on the large chromosome is likely to be more
closely related to V. cholerae O1 El Tor variant strains
currently circulating in Bangladesh (Nair et al., 2006),
India (Goel et al., 2010) and Thailand (Okada et al., 2010).
However, our data are insufficient to verify the source of
the V. cholerae O1 strains currently circulating in Vietnam.
Most of the strains from Vietnam were multi-drug resistant
with common resistance to nalidixic acid, co-trimoxazole
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cline. Resistance to tetracycline, a common antimicrobial
agent for the treatment of cholera (WHO, 2005), was also
high (29%). Both tetracycline and doxycycline belong to
the tetracycline antibiotic group and cross-resistance
between these agents exists (Fluit et al., 2005). The use of
doxycycline for cholera treatment and the trend of V.
cholerae O1 resistance to the tetracycline group of anti-
biotics should be monitored. All isolates were resistant to
co-trimoxazole, a recommended first-line agent for chil-
dren with diarrhoea. A high incidence of co-trimoxazole
resistance in V. cholerae O1 strains has been reported in
prior studies in Africa, Asia and South America (Goel &
Jiang, 2010; Ibarra & Alvarado, 2007; Mandomando et al.,
2007). In Vietnam, there is also an increase in resistance to
co-trimoxazole among diarrhoeagenic strains of E. coli and
Shigella isolated from children in Hanoi (Nguyen et al.,
2005). This indicates that co-trimoxazole should not be
the recommended treatment for children with diarrhoea in
Vietnam.
All the O1 V. cholerae strains were susceptible to fluoro-
quinolones, including ciprofloxacin and levofloxacin.
However, the MIC90 of ciprofloxacin was close to the
susceptibility breakpoint of 1 mg l
21. All the V. cholerae O1
strains from Vietnam were completely resistant to nalidixic
acid (MIC 256 mgm l
21). V. cholerae O1 strains resistant to
fluoroquinolones have been reported from India (Krishna
et al., 2006). The high incidence of nalidixic acid resistance
in V. cholerae O1 and increased resistance of V. cholerae
against ciprofloxacin is cause for concern (Islam et al.,
2009). Although the MICs of ciprofloxacin for the
Vietnamese V. cholerae O1 strains were still below the
susceptibility breakpoint, they had increased compared to
historical isolates; this may be an indication of the
emergence of high-level fluoroquinolone resistance in the
near future. The majority of the Vietnamese strains (95%)
were still susceptible to azithromycin and this antibiotic
can still be used for treatment in Vietnam, though further
development of resistance needs to be monitored.
Azithromycin is used for treatment of diarrhoeal diseases
worldwide (de Saussure, 2009) and has shown to be
effective in treatment of cholera in children and adults
(Saha et al., 2006). In general, the Vietnamese V. cholerae
strains showed similar resistance patterns to Indian and
Thai strains of the altered V. cholerae O1 El Tor biotype,
carrying the classical ctxB allele; a new variant of V. cholerae
O1 (Jain et al., 2011; Okada et al., 2010).
Conclusion
Between 2007 and 2010, cholera outbreaks in Vietnam have
been caused by a single clone of a variant V. cholerae O1
biotype El Tor strain. This variant was closely linked to
similar variants of V. cholerae O1 El Tor strains isolated in
Bangladesh and Zimbabwe but had a slightly divergent
lineage, suggesting that they have evolved in solitary and
independent ecosystem. A significant proportion of strains
were multi-drug resistant, although the majority were still
borderline susceptible to fluoroquinolones and susceptible
to azithromycin. Empirical treatment of cholera with
fluoroquinolones needs to be reconsidered.
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